Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Lee, Ho-Young"" wg kryterium: Autor


Wyświetlanie 1-10 z 10
Tytuł:
Successful treatment of induced oligometastasis and repeated oligoprogression of advanced lung adenocarcinoma with immunotherapy and radiotherapy.
Autorzy:
Lee HY; Department of Internal Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Inje University Busan Paik Hospital, College of Medicine, Busan, Republic of Korea.
Kim SH; Department of Internal Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Inje University Busan Paik Hospital, College of Medicine, Busan, Republic of Korea.
Lee HY; Department of Internal Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Inje University Busan Paik Hospital, College of Medicine, Busan, Republic of Korea.
Lee YM; Department of Internal Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Inje University Busan Paik Hospital, College of Medicine, Busan, Republic of Korea.
Han JY; Department of Radiology, Inje University Busan Paik Hospital, College of Medicine, Busan, Republic of Korea.
Cho H; Department of Radiation Oncology, Inje University Busan Paik Hospital, College of Medicine, Busan, Republic of Korea.
Lee HK; Department of Internal Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Inje University Busan Paik Hospital, College of Medicine, Busan, Republic of Korea.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2022 Jul; Vol. 13 (13), pp. 1998-2000. Date of Electronic Publication: 2022 May 22.
Typ publikacji:
Case Reports
MeSH Terms:
Adenocarcinoma of Lung*/radiotherapy
Lung Neoplasms*/pathology
Radiosurgery*
Humans ; Immunotherapy
Raport
Tytuł:
Ninjurin1 drives lung tumor formation and progression by potentiating Wnt/β-Catenin signaling through Frizzled2-LRP6 assembly.
Autorzy:
Hyun SY; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
Min HY; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
Lee HJ; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Cho J; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
Boo HJ; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
Noh M; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Jang HJ; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Lee HJ; School of Pharmacy, Sungkyunkwan University, Suwon-Si, Gyeonggi-do, 16419, Republic of Korea.
Park CS; Soonchunhyang University Bucheon Hospital, Bucheon-si, Gyeonggi-do, 14584, Republic of Korea.
Park JS; Soonchunhyang University Bucheon Hospital, Bucheon-si, Gyeonggi-do, 14584, Republic of Korea.
Shin YK; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Lee HY; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea. .; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2022 Apr 08; Vol. 41 (1), pp. 133. Date of Electronic Publication: 2022 Apr 08.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/pathology
Cell Adhesion Molecules, Neuronal*/genetics
Lung Neoplasms*/pathology
Nerve Growth Factors*/genetics
Wnt Signaling Pathway*
Animals ; Carcinogenesis/genetics ; Cell Line, Tumor ; Frizzled Receptors ; Humans ; Low Density Lipoprotein Receptor-Related Protein-6/genetics ; Mice ; Tumor Microenvironment ; beta Catenin/metabolism
Czasopismo naukowe
Tytuł:
A Ras destabilizer KYA1797K overcomes the resistance of EGFR tyrosine kinase inhibitor in KRAS-mutated non-small cell lung cancer.
Autorzy:
Park J; Translational Research Center for Protein Function Control, Yonsei University, Seoul, Korea.; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
Cho YH; Translational Research Center for Protein Function Control, Yonsei University, Seoul, Korea.; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
Shin WJ; Translational Research Center for Protein Function Control, Yonsei University, Seoul, Korea.; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
Lee SK; Translational Research Center for Protein Function Control, Yonsei University, Seoul, Korea.; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
Lee J; Translational Research Center for Protein Function Control, Yonsei University, Seoul, Korea.; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
Kim T; Translational Research Center for Protein Function Control, Yonsei University, Seoul, Korea.; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
Cha PH; Translational Research Center for Protein Function Control, Yonsei University, Seoul, Korea.; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
Yang JS; Translational Research Center for Protein Function Control, Yonsei University, Seoul, Korea.; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
Cho J; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.
Min DS; Translational Research Center for Protein Function Control, Yonsei University, Seoul, Korea.; Department of Molecular Biology, College of Natural Science, Pusan National University, Pusan, Korea.
Han G; Translational Research Center for Protein Function Control, Yonsei University, Seoul, Korea.; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
Lee HY; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.
Choi KY; Translational Research Center for Protein Function Control, Yonsei University, Seoul, Korea. .; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Jan 24; Vol. 9 (1), pp. 648. Date of Electronic Publication: 2019 Jan 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung/*pathology
Drug Resistance, Neoplasm/*genetics
Lung Neoplasms/*pathology
Proto-Oncogene Proteins p21(ras)/*genetics
Thiazolidines/*pharmacology
ras Proteins/*metabolism
Animals ; Cell Line, Tumor ; Cell Proliferation/drug effects ; ErbB Receptors/antagonists & inhibitors ; Erlotinib Hydrochloride/pharmacology ; Gene Expression Regulation, Neoplastic/drug effects ; HEK293 Cells ; Humans ; MAP Kinase Signaling System/drug effects ; Mice ; Protein Kinase Inhibitors/pharmacology ; Protein Stability/drug effects ; beta Catenin/metabolism
Czasopismo naukowe
Tytuł:
Development of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer.
Autorzy:
Hyun SY; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
Le HT; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
Nguyen CT; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
Yong YS; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Boo HJ; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
Lee HJ; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
Lee JS; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Min HY; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Ann J; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
Chen J; School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, 16419, South Korea.
Park HJ; School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, 16419, South Korea.
Lee J; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
Lee HY; Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea. .; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea. .; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2018 Sep 17; Vol. 8 (1), pp. 13924. Date of Electronic Publication: 2018 Sep 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*chemical synthesis
Benzopyrans/*chemical synthesis
Carcinoma, Non-Small-Cell Lung/*pathology
HSP90 Heat-Shock Proteins/*antagonists & inhibitors
Lung Neoplasms/*pathology
Pyridines/*chemical synthesis
Adenosine Triphosphate/metabolism ; Antineoplastic Agents/pharmacology ; Benzopyrans/pharmacology ; Binding Sites ; Carcinoma, Non-Small-Cell Lung/metabolism ; Cell Line, Tumor ; Cell Survival/drug effects ; HSP90 Heat-Shock Proteins/metabolism ; Humans ; Inhibitory Concentration 50 ; Lung Neoplasms/metabolism ; Pyridines/pharmacology
Czasopismo naukowe
Tytuł:
Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer.
Autorzy:
Min HY; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, Republic of Korea. .
Yun HJ; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, Republic of Korea. .
Lee JS; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, Republic of Korea. .
Lee HJ; College of Pharmacy, Inje University, Gimhae, Gyungnam, 621-749, Republic of Korea. .
Cho J; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, Republic of Korea. .
Jang HJ; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, Republic of Korea. .
Park SH; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, Republic of Korea. .
Liu D; Department of Biostatistics, The University of Texas M. D. Anderson Cancer Cener, Houston, TX, USA. .
Oh SH; College of Pharmacy, Gachon University, Incheon, 406-840, Republic of Korea. .
Lee JJ; Department of Biostatistics, The University of Texas M. D. Anderson Cancer Cener, Houston, TX, USA. .
Wistuba II; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Cener, Houston, TX, USA. .; Department of Pathology, The University of Texas M. D. Anderson Cancer Cener, Houston, TX, USA. .
Lee HY; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, Republic of Korea. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2015 Jun 04; Vol. 14, pp. 113. Date of Electronic Publication: 2015 Jun 04.
Typ publikacji:
Journal Article
MeSH Terms:
Molecular Targeted Therapy*
Signal Transduction*/drug effects
Carcinoma, Non-Small-Cell Lung/*drug therapy
Lung Neoplasms/*drug therapy
Receptor, IGF Type 1/*metabolism
src-Family Kinases/*metabolism
Animals ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Line, Tumor ; Drug Resistance, Neoplasm/drug effects ; Humans ; Imidazoles/pharmacology ; Lung Neoplasms/pathology ; Mice ; Models, Biological ; Phosphorylation/drug effects ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Protein Stability/drug effects ; Pyrazines/pharmacology
Czasopismo naukowe
Tytuł:
Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer.
Autorzy:
Chang YS; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Box 432, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Wang L
Suh YA
Mao L
Karpen SJ
Khuri FR
Hong WK
Lee HY
Pokaż więcej
Źródło:
Oncogene [Oncogene] 2004 Aug 26; Vol. 23 (39), pp. 6569-80.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Carcinoma, Non-Small-Cell Lung/*metabolism
Insulin-Like Growth Factor Binding Protein 3/*physiology
Lung Neoplasms/*metabolism
Base Sequence ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Line, Tumor ; DNA Methylation ; DNA, Neoplasm ; DNA-Binding Proteins/metabolism ; Humans ; Insulin-Like Growth Factor Binding Protein 3/metabolism ; Lung Neoplasms/pathology ; Molecular Sequence Data ; Promoter Regions, Genetic ; Sp1 Transcription Factor/metabolism ; Sp3 Transcription Factor ; Transcription Factors/metabolism
Czasopismo naukowe
Tytuł:
Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer.
Autorzy:
Wang L; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Soria JC
Chang YS
Lee HY
Wei Q
Mao L
Pokaż więcej
Źródło:
Oncogene [Oncogene] 2003 Oct 16; Vol. 22 (46), pp. 7123-9.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Carcinoma, Non-Small-Cell Lung/*genetics
Lung Neoplasms/*genetics
Minisatellite Repeats/*genetics
Tandem Repeat Sequences/*genetics
Telomerase/*genetics
Base Sequence ; Carcinoma, Non-Small-Cell Lung/surgery ; DNA Primers ; DNA-Binding Proteins ; Genes, Reporter ; Genetic Variation ; Genotype ; Humans ; Luciferases/genetics ; Lung Neoplasms/surgery ; Plasmids ; Promoter Regions, Genetic ; RNA Probes ; Reverse Transcriptase Polymerase Chain Reaction ; Transcription, Genetic ; Transfection ; Tumor Cells, Cultured
Czasopismo naukowe
    Wyświetlanie 1-10 z 10

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies